Eli Lilly Says FDA Approves Mounjaro, a Dual GIP and GLP-1 Hormone Receptor Agonist, to Lower Risk of Major Adverse Cardiovascular Events in Adults with Type 2 Diabetes

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.